Contego Medical, a Raleigh, NC-based provider of the Integrated Embolic Protection™ filter platform for angioplasty balloon and stent delivery catheters, completed a $5.6m Series B financing.
The round was led by Hatteras Venture Partners, with partipation from Mountain Group Partners, Lookout Capital and Medical Mutual. In conjunction with the funding, Doug Reed MD, General Partner of Hatteras Venture Partners, will be joining Contego Medical as a board member.
The company will use the funds to continue to grow its leadership, sales and engineering teams and to develop new products.
Led by Ravish Sachar MD, Founder and CEO, Paul Sanders, COO, Udayan Patel, CTO, Alan Bacharach, European General Manager, and Elizabeth Saylors, VP of Quality and Clinical Affairs, Contego Medical is developing a portfolio of novel medical devices to innovate the field of cardiovascular and endovascular intervention by enabling embolic protection with every procedure. Its Paladin® Carotid Post-Dilation Balloon with Integrated Embolic Protection is CE-marked in Europe while not for sale in the US.